Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution

American Journal of Hematology
Stéphanie GuilletEric Oksenhendler

Abstract

Human immunodeficiency virus (HIV)-associated primary effusion lymphoma (PEL) is a rare B-cell non-Hodgkin lymphoma with poor prognosis. Lymphoma cells are always infected with human herpesvirus-8 (HHV-8) and in most cases coinfected with Epstein-Barr virus. In classic presentation, PEL is characterized by body cavity effusions with or without mass lesions. A variant with only extracavitary localization has also been described. We report on a large single-center series of patients with PEL in the era of combined antiretroviral therapy (cART). The main objective was to compare the characteristics and the outcome of patients with classic (n = 34) and extracavitary (n = 17) variant PEL. At PEL diagnosis, no major difference was observed between the two groups in terms of demographic and HIV characteristics. Extracavitary localizations were exclusively nodal in six patients and involved various organs in 11 patients. Another HHV-8-associated disease was observed in 31 patients, Kaposi sarcoma in 25, and multicentric Castleman disease in 18 patients, without difference between the two groups. Thirty-two patients were treated with CHOP associated with high-dose methotrexate, 13 were treated with CHOP-derived regimen alone, and six pa...Continue Reading

References

May 4, 1995·The New England Journal of Medicine·E CesarmanD M Knowles
Jan 9, 2003·The Lancet Oncology·Antonino Carbone
Jun 27, 2003·American Journal of Hematology·Emmanuelle BoulangerEric Oksenhendler
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cecelia SimonelliUmberto Tirelli
Oct 19, 2004·The American Journal of Surgical Pathology·Amy ChadburnDaniel M Knowles
May 11, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soon Thye LimAlexandra M Levine
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emmanuelle BoulangerEric Oksenhendler
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
May 25, 2007·The Oncologist·Yi-Bin ChenEphraim Hochberg
Apr 14, 2012·Annals of Diagnostic Pathology·Yoonjung KimFrancisco Vega
Feb 21, 2013·The Thoracic and Cardiovascular Surgeon·Zaid A AmmariMalek G Massad
Sep 4, 2013·Seminars in Cancer Biology·Annunziata GloghiniAntonino Carbone
Oct 1, 2013·The American Journal of Surgical Pathology·Antonino CarboneAnnunziata Gloghini
Jan 30, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S K BartaJ A Sparano

❮ Previous
Next ❯

Citations

Sep 30, 2016·Archives of Pathology & Laboratory Medicine·Charles M Harmon, Lauren B Smith
Apr 12, 2017·Current Opinion in Pulmonary Medicine·Nivedita AroraNavid Sadeghi
Mar 15, 2018·The New England Journal of Medicine·Robert Yarchoan, Thomas S Uldrick
Jul 25, 2018·Archives of Pathology & Laboratory Medicine·Richard Luther Attanoos, Matthew Richard Pugh
Mar 9, 2018·Diagnostic Cytopathology·Meng-Chen TsaiShih-Sung Chuang
Sep 14, 2018·AIDS·Bal Mukunda DhungelSatish Gopal
Jan 24, 2019·International Journal of Hematology·Jose D Sandoval-SusMarco Ruiz
Feb 21, 2019·Blood·Kathryn LurainThomas S Uldrick
Jun 14, 2017·AIDS·Priscila H GonçalvesRobert Yarchoan
Aug 30, 2018·Blood·Kazuyuki ShimadaHitoshi Kiyoi
Nov 15, 2019·Advances in Anatomic Pathology·Bo-Jung Chen, Shih-Sung Chuang
Oct 9, 2019·The American Journal of Dermatopathology·Andrea SagginiLucia Anemona
May 26, 2020·Leukemia & Lymphoma·Cristian AguilarJorge J Castillo
Mar 7, 2019·Blood Advances·Victoria A ChangErin G Reid
Jul 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Jason P WongBlossom Damania
Jul 29, 2020·Viruses·Monika A ZelazowskaLaurie T Krug
Aug 18, 2020·Current Oncology Reports·Kai Hübel
Feb 16, 2019·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Junghoon ShinUNKNOWN Consortium for Improving Survival of Lymphoma investigators
Dec 3, 2020·Diagnostics·Paola ParentePaolo Graziano
Aug 30, 2017·Molecular Cancer Therapeutics·Feng ZhouYoshihiro Izumiya
Jan 28, 2021·Cancers·Francesca SanguedolceStefano Ascani
Nov 19, 2019·Pathology·Narittee SukswaiL Jeffrey Medeiros
Jun 5, 2020·The Cancer Journal·Ariela Noy
Nov 6, 2020·BMJ Case Reports·Darakhshan Sohail AhmedJean-Pierre Routy
Aug 10, 2020·Seminars in Diagnostic Pathology·May FuFranklin Fuda
May 15, 2021·Seminars in Diagnostic Pathology·Ashley K VolaricAlejandro A Gru
Jul 6, 2021·Frontiers in Oncology·Ricardo Rivera-SotoBlossom Damania
Jul 12, 2021·Bulletin du cancer·Illias Tazi, Fatima Zahra Lahlimi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.